Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?

Saved in:
Bibliographic Details
Published in:Neuropsychopharmacology (New York, N.Y.) N.Y.), 2020-04, Vol.45 (5), p.717-719
Main Authors: James, Morgan H, Fragale, Jennifer E, Aurora, R Nisha, Cooperman, Nina A, Langleben, Daniel D, Aston-Jones, Gary
Format: Article
Language:English
Subjects:
Addictions
Animals
Azepines - administration & dosage
Azepines - therapeutic use
Bioavailability
Comorbidity
Craving - drug effects
Drug addiction
Drug dosages
Drug Repositioning
Drug withdrawal
FDA approval
Humans
Insomnia
Narcotics
Opioid receptors
Opioid-Related Disorders - drug therapy
Orexin Receptor Antagonists - administration & dosage
Orexin Receptor Antagonists - therapeutic use
Orexins
Sleep
Sleep disorders
Substance abuse treatment
Substance use disorder
Triazoles - administration & dosage
Triazoles - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0893-133X
1740-634X
DOI:10.1038/s41386-020-0619-x